HERBESSER R200 CAPSULE 200mg

Product Information

Registration Status: Active

HERBESSER R200 CAPSULE 200mg is approved to be sold in Singapore with effective from 1998-09-29. It is marketed by PHARMAFORTE SINGAPORE PTE LTD, with the registration number of SIN10061P.

This product contains Diltiazem 200mg in the form of CAPSULE. It is approved for ORAL use.

This product is manufactured by PT Tanabe Indonesia in INDONESIA REP OF, andMitsubishi Tanabe Pharma Factory Ltd in JAPAN.

It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.

Diltiazem

Description

A benzothiazepine derivative with vasodilating action due to its antagonism of the actions of the calcium ion in membrane functions. It is also teratogenic.

Indication

For the treatment of Hypertension

Mechanism of Action

Possibly by deforming the channel, inhibiting ion-control gating mechanisms, and/or interfering with the release of calcium from the sarcoplasmic reticulum, diltiazem, like verapamil, inhibits the influx of extracellular calcium across both the myocardial and vascular smooth muscle cell membranes. The resultant inhibition of the contractile processes of the myocardial smooth muscle cells leads to dilation of the coronary and systemic arteries and improved oxygen delivery to the myocardial tissue.

Pharmacokinetics

Absorption
Diltiazem is well absorbed from the gastrointestinal tract but undergoes substantial hepatic first-pass effect.
Distribution
Metabolism
Diltiazem is metabolized by and acts as an inhibitor of the CYP3A4 enzyme.
Elimination

Toxicity

LD50=740mg/kg (orally in mice)

Active Ingredient/Synonyms

(+)-cis-5-[2-(dimethylamino)ethyl]-2,3-dihydro-3-hydroxy-2-(p-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one acetate ester | (2S-cis)-3-(acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one | (2S,3S)-5-(2-(dimethylamino)ethyl)-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-3-yl acetate | Acetic acid (2S,3S)-5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester | D-cis-diltiazem | Diltiazem | Diltiazemum | Diltiazem |


Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.

References

  1. Health Science Authority of Singapore - Reclassified POM
  2. Drugbank